All the latest news and information on the cannabis and psychedelics industries, with updates from the UK and across the globe.
At Volteface we have talked extensively about the barriers to access the UK medical cannabis market, from a lack of awareness regarding legality to a shortfall in the number of…
In the first episode of Volteface TV Paul North, Director of Volteface speaks to Alastair Moore of The Hanway Company about the recently confirmed plans for cannabis legalisation in Germany.…
When the US midterms come around it’s always sure to be an interesting time for politics and drug policy, and this year’s midterms were no exception. Drugs were on the…
As we previously reported, Germany’s plans to legalise cannabis were leaked on 19th October. Key details from the unofficial documents and early-stage German proposals leaked to the press included: A…
Many psychological and neurological disorders are inadequately addressed by existing drugs. Treatment resistance affects around 20-60% of patients with a psychiatric disorder, and 33% of those suffering from a neurological…
Key aspects of the German government’s plans to create a legalised recreational cannabis market, following in the footsteps of countries such as Canada, Malta and Mexico have been leaked. These…
Referred to as the ‘green wave’, the cannabis sector is undeniably on the rise across Europe, with policy changes in both the medicinal and recreational spheres. BSDA predicts that global…
The current cost of living crisis has impacted individuals and businesses alike, and it appears that the medical cannabis industry is not exempt from the injurious effects of inflation, soaring…
Tuesday 1st November 2022 will mark four years exactly since medical cannabis was finally legalised in the UK. Despite the change in the law, there are a number of recurring…
When you hear the word ‘radiation’, it probably doesn’t conjure up the best images. We know that at certain doses, exposure to radiation can damage DNA in our cells, cause…
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept